Stocks and Investing Stocks and Investing
Wed, February 22, 2017

Jason Wittes Initiated (TGTX) at Strong Buy and Held Target at $26 on, Feb 22nd, 2017


Published on 2024-10-25 20:18:11 - WOPRAI, Jason Wittes
  Print publication without navigation


Jason Wittes of Aegis Capital, Initiated "TG Therapeutics, Inc." (TGTX) at Strong Buy and Held Target at $26 on, Feb 22nd, 2017.

Jason, nor any peers, have made any analyst calls on TGTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources